OpenVSafe by OpenVAERS
Search V-safe

997-31619-08944

3 vaccinations 2 coded responses 9 check-ins 2 free-text entries 0 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
647 / MO
Registered
2021-03-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-01
    Registered in v-safe
  3. 2021-03-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-03-02
    Dose 2 — Pfizer-BioNTech
  5. 2021-03-02
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-09
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-16
    Survey response — day 14, dose 2
    MedDRA: Blood glucose fluctuation — Feeling: Good
    Free text: Persistent rise in blood sugar level since first shot. Initially after first shot, then two weeks later. A trend of three high days, then a normal one. Levels common between 250-325 with minimal overnight drops. (Type II diabetic)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-24
    Survey response — day 21, dose 2
    MedDRA: Blood glucose increased — Feeling: Good
    Free text: Continued high blood sugar levels above 200. I fasted for 24 hours; my blood sugar dipped to 72 after 20 units of insulin, Metformin, and Glimeperide. Then, I ate a protein bar; reading climbed to 125. Had coffee with oat milk; readings 200+ for 12h.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-09-25
    Dose 3 — Pfizer-BioNTech

Vaccinations

DoseDateManufacturerCo-administered
12021-02-09Pfizer-BioNTech
22021-03-02Pfizer-BioNTech
32021-09-25Pfizer-BioNTech No

Free text

Release 5 — day 14, dose 2

2021-03-16

Symptoms: Persistent rise in blood sugar level since first shot. Initially after first shot, then two weeks later. A trend of three high days, then a normal one. Levels common between 250-325 with minimal overnight drops. (Type II diabetic)

Release 6 — day 21, dose 2

2021-03-24

Symptoms: Continued high blood sugar levels above 200. I fasted for 24 hours; my blood sugar dipped to 72 after 20 units of insulin, Metformin, and Glimeperide. Then, I ate a protein bar; reading climbed to 125. Had coffee with oat milk; readings 200+ for 12h. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood glucose fluctuation ✓ ✓ ✓
SDBlood glucose increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release